Chairman and CEO Lou Jing increased his holdings in 3SBIO (01530) by 516,000 shares at a price of HK$15.2497 per share.
On June 8, Chairman and CEO Lou Jing increased his holdings in Sanofi Pharmaceutical (01530) by 516,000 shares, with a price of HK$15.2497 per share, for a total amount of approximately HK$7.8688 million.
The latest data from the Hong Kong Stock Exchange shows that on June 8, Chairman and CEO Lou Jing increased his holdings of 3SBIO (01530) by 516,000 shares, with a price of HK$15.2497 per share, for a total amount of approximately HK$7.8688 million. After the increase, the latest number of shares held is approximately 534 million, with a new shareholding percentage of 21.03%.
Additional information: Dr. Lou Jing is an enforcer and a beneficiary of an unnamed discretionary trust.
Related Articles
PETROCHINA(00857): Adjustment of Board Committee Members
Air China Limited (00753) has completed the issuance of approximately 3.044 billion A shares to China Aviation Group and AVIC Holdings, raising approximately RMB 19.99 billion net.
Guangdong Misun Technology (301577.SZ): Runke Fund plans to reduce its holdings of the company's shares by no more than 0.9283%.
PETROCHINA(00857): Adjustment of Board Committee Members
Air China Limited (00753) has completed the issuance of approximately 3.044 billion A shares to China Aviation Group and AVIC Holdings, raising approximately RMB 19.99 billion net.
Guangdong Misun Technology (301577.SZ): Runke Fund plans to reduce its holdings of the company's shares by no more than 0.9283%.
